secwatch.observer — SEC 8-K summary
======================================

Issuer:     PharmaCyte Biotech, Inc. (PMCB)
CIK:        0001157075
Form:       8-K
Filed at:   2025-02-26T23:59:59+00:00
Accession:  0001683168-25-001236
Event type: other
Sentiment:  negative
Materiality: 0.25
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PharmaCyte Biotech auditor Marcum resigns, replaced by CBIZ CPAs P.C.; material weaknesses reiterated
--------------------------------------------------------------------------------

- Marcum LLP resigned as independent auditor on Feb 21, 2025, effective upon CBIZ CPAs P.C. acquiring Marcum's attest business.
- Audit Committee immediately engaged CBIZ CPAs P.C. as successor independent registered public accounting firm.
- No disagreements with Marcum on accounting principles or audit scope during FYE April 30, 2024 or interim period.
- Material weaknesses disclosed in prior 10-K remain: insufficient segregation of CFO duties and insufficient management review controls.
- Marcum provided letter to SEC agreeing with the company's statements regarding the change.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1157075/000168316825001236/0001683168-25-001236-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1157075/000168316825001236/pharmacyte_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-001236

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer